• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢型谷氨酸受体激活和内化的正向变构调节的结构基础。

Structural basis of positive allosteric modulation of metabotropic glutamate receptor activation and internalization.

作者信息

Strauss Alexa, Gonzalez-Hernandez Alberto J, Lee Joon, Abreu Nohely, Selvakumar Purushotham, Salas-Estrada Leslie, Kristt Melanie, Arefin Anisul, Huynh Kevin, Marx Dagan C, Gilliland Kristen, Melancon Bruce J, Filizola Marta, Meyerson Joel, Levitz Joshua

机构信息

Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA.

Tri-Institutional Program in Chemical Biology, New York, NY, 10065, USA.

出版信息

Nat Commun. 2024 Aug 1;15(1):6498. doi: 10.1038/s41467-024-50548-x.

DOI:10.1038/s41467-024-50548-x
PMID:39090128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11294631/
Abstract

The metabotropic glutamate receptors (mGluRs) are neuromodulatory family C G protein coupled receptors which assemble as dimers and allosterically couple extracellular ligand binding domains (LBDs) to transmembrane domains (TMDs) to drive intracellular signaling. Pharmacologically, mGluRs can be targeted at the LBDs by glutamate and synthetic orthosteric compounds or at the TMDs by allosteric modulators. Despite the potential of allosteric compounds as therapeutics, an understanding of the functional and structural basis of their effects is limited. Here we use multiple approaches to dissect the functional and structural effects of orthosteric versus allosteric ligands. We find, using electrophysiological and live cell imaging assays, that both agonists and positive allosteric modulators (PAMs) can drive activation and internalization of group II and III mGluRs. The effects of PAMs are pleiotropic, boosting the maximal response to orthosteric agonists and serving independently as internalization-biased agonists across mGluR subtypes. Motivated by this and intersubunit FRET analyses, we determine cryo-electron microscopy structures of mGluR3 in the presence of either an agonist or antagonist alone or in combination with a PAM. These structures reveal PAM-driven re-shaping of intra- and inter-subunit conformations and provide evidence for a rolling TMD dimer interface activation pathway that controls G protein and beta-arrestin coupling.

摘要

代谢型谷氨酸受体(mGluRs)是C族神经调节性G蛋白偶联受体,以二聚体形式组装,并通过变构作用将细胞外配体结合结构域(LBDs)与跨膜结构域(TMDs)偶联,以驱动细胞内信号传导。在药理学上,mGluRs可通过谷氨酸和合成的正构配体靶向LBDs,或通过变构调节剂靶向TMDs。尽管变构化合物具有作为治疗药物的潜力,但对其作用的功能和结构基础的了解仍然有限。在这里,我们使用多种方法来剖析正构配体与变构配体的功能和结构效应。我们通过电生理和活细胞成像分析发现,激动剂和正变构调节剂(PAMs)都可以驱动II组和III组mGluRs的激活和内化。PAMs的作用是多效性的,增强了对正构激动剂的最大反应,并在mGluR亚型中独立作为内化偏向激动剂起作用。受此以及亚基间荧光共振能量转移分析的启发,我们确定了单独存在激动剂或拮抗剂或与PAM结合时mGluR3的冷冻电子显微镜结构。这些结构揭示了PAM驱动的亚基内和亚基间构象重塑,并为控制G蛋白和β-抑制蛋白偶联的滚动TMD二聚体界面激活途径提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/234198c218e0/41467_2024_50548_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/0d29b9d4b2db/41467_2024_50548_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/6e636ee69fa5/41467_2024_50548_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/016ba7a2d765/41467_2024_50548_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/6f1fe76c2cef/41467_2024_50548_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/acabc749005e/41467_2024_50548_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/234198c218e0/41467_2024_50548_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/0d29b9d4b2db/41467_2024_50548_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/6e636ee69fa5/41467_2024_50548_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/016ba7a2d765/41467_2024_50548_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/6f1fe76c2cef/41467_2024_50548_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/acabc749005e/41467_2024_50548_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e77/11294631/234198c218e0/41467_2024_50548_Fig6_HTML.jpg

相似文献

1
Structural basis of positive allosteric modulation of metabotropic glutamate receptor activation and internalization.代谢型谷氨酸受体激活和内化的正向变构调节的结构基础。
Nat Commun. 2024 Aug 1;15(1):6498. doi: 10.1038/s41467-024-50548-x.
2
Structural basis of allosteric modulation of metabotropic glutamate receptor activation and desensitization.代谢型谷氨酸受体激活和脱敏变构调节的结构基础。
bioRxiv. 2023 Aug 14:2023.08.13.552748. doi: 10.1101/2023.08.13.552748.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Metabotropic glutamate receptor homo- and heterodimers exhibit distinct responses to orthosteric and allosteric ligands.代谢型谷氨酸受体同二聚体和异二聚体对正构配体和变构配体表现出不同的反应。
Mol Pharmacol. 2025 Jul 18;107(9):100063. doi: 10.1016/j.molpha.2025.100063.
5
Pharmacological characterisation of allosteric modulators at human mGlu.人代谢型谷氨酸受体变构调节剂的药理学特性研究
Biochem Pharmacol. 2025 Sep;239:117030. doi: 10.1016/j.bcp.2025.117030. Epub 2025 Jun 6.
6
Structure-based discovery of positive allosteric modulators of the A adenosine receptor.基于结构的A1腺苷受体正变构调节剂的发现
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2421687122. doi: 10.1073/pnas.2421687122. Epub 2025 Jul 7.
7
Evaluation of allosteric N-methyl-d-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modeling.使用药理学平衡模型评估GluN2A选择性拮抗剂对变构N-甲基-D-天冬氨酸受体的调节作用。
Mol Pharmacol. 2025 Jan;107(1):100004. doi: 10.1124/molpharm.124.000975. Epub 2024 Nov 22.
8
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
Conformational dynamics between transmembrane domains and allosteric modulation of a metabotropic glutamate receptor.跨膜结构域之间的构象动力学和代谢型谷氨酸受体的别构调节。
Elife. 2019 Jun 7;8:e45116. doi: 10.7554/eLife.45116.
10
Brexanolone, zuranolone and related neurosteroid GABA receptor positive allosteric modulators for postnatal depression.用于产后抑郁症的布雷沙诺龙、祖拉诺龙及相关神经甾体GABA受体正变构调节剂。
Cochrane Database Syst Rev. 2025 Jun 26;6(6):CD014624. doi: 10.1002/14651858.CD014624.pub2.

引用本文的文献

1
Upregulation of NR2A in Glutamatergic VTA Neurons Contributes to Chronic Visceral Pain in Male Mice.谷氨酸能腹侧被盖区神经元中NR2A的上调导致雄性小鼠慢性内脏痛。
Neurosci Bull. 2025 Apr 28. doi: 10.1007/s12264-025-01402-7.
2
Domain coupling in activation of a family C GPCR.C类G蛋白偶联受体激活过程中的结构域偶联
Nat Chem Biol. 2025 Apr 25. doi: 10.1038/s41589-025-01895-3.
3
Molecular Glues: A New Approach to Modulating GPCR Signaling Bias.分子胶:调节G蛋白偶联受体信号偏向性的新方法。

本文引用的文献

1
Distinct beta-arrestin coupling and intracellular trafficking of metabotropic glutamate receptor homo- and heterodimers.代谢型谷氨酸受体同型和异型二聚体的独特β-arrestin 偶联和细胞内转运。
Sci Adv. 2023 Dec 8;9(49):eadi8076. doi: 10.1126/sciadv.adi8076. Epub 2023 Dec 6.
2
Structural insights into dimerization and activation of the mGlu2-mGlu3 and mGlu2-mGlu4 heterodimers.结构洞察 mGlu2-mGlu3 和 mGlu2-mGlu4 异二聚体的二聚化和激活。
Cell Res. 2023 Oct;33(10):762-774. doi: 10.1038/s41422-023-00830-2. Epub 2023 Jun 8.
3
Concerted conformational changes control metabotropic glutamate receptor activity.
Biochemistry. 2025 Feb 18;64(4):749-759. doi: 10.1021/acs.biochem.4c00734. Epub 2025 Feb 3.
4
Group III metabotropic glutamate receptors: guardians against excitotoxicity in ischemic brain injury, with implications for neonatal contexts.III 型代谢型谷氨酸受体:对抗缺血性脑损伤中兴奋性毒性的守护者,对新生儿情况有影响。
Pharmacol Rep. 2024 Dec;76(6):1199-1218. doi: 10.1007/s43440-024-00651-z. Epub 2024 Sep 17.
协同构象变化控制代谢型谷氨酸受体活性。
Sci Adv. 2023 Jun 2;9(22):eadf1378. doi: 10.1126/sciadv.adf1378.
4
Control of Gα signaling dynamics and GPCR cross-talk by GRKs.GRK对Gα信号动力学和GPCR相互作用的调控
Sci Adv. 2022 Nov 25;8(47):eabq3363. doi: 10.1126/sciadv.abq3363.
5
G protein-coupled receptor interactions with arrestins and GPCR kinases: The unresolved issue of signal bias.G 蛋白偶联受体与阻滞蛋白和 GPCR 激酶的相互作用:信号偏向的未解决问题。
J Biol Chem. 2022 Sep;298(9):102279. doi: 10.1016/j.jbc.2022.102279. Epub 2022 Jul 19.
6
Emerging structural insights into GPCR-β-arrestin interaction and functional outcomes.新兴的结构洞察揭示了 G 蛋白偶联受体-β-arrestin 相互作用和功能结果。
Curr Opin Struct Biol. 2022 Aug;75:102406. doi: 10.1016/j.sbi.2022.102406. Epub 2022 Jun 20.
7
Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.变构调节代谢型谷氨酸受体作为神经精神疾病治疗的新策略。
Pharmacol Rev. 2022 Jul;74(3):630-661. doi: 10.1124/pharmrev.121.000540.
8
Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia.代谢型谷氨酸受体作为精神分裂症治疗的新兴靶点。
Mol Pharmacol. 2022 May;101(5):275-285. doi: 10.1124/molpharm.121.000460. Epub 2022 Mar 3.
9
Structural basis of the activation of metabotropic glutamate receptor 3.代谢型谷氨酸受体3激活的结构基础
Cell Res. 2022 Jul;32(7):695-698. doi: 10.1038/s41422-022-00623-z. Epub 2022 Mar 2.
10
Agonists and allosteric modulators promote signaling from different metabotropic glutamate receptor 5 conformations.激动剂和别构调节剂促进不同代谢型谷氨酸受体 5 构象的信号转导。
Cell Rep. 2021 Aug 31;36(9):109648. doi: 10.1016/j.celrep.2021.109648.